742666-57-5

Basic information

• Product Name: METHYL ISOINDOLINE-5-CARBOXYLATE
• Synonyms: METHYL ISOINDOLINE-5-CARBOXYLATE;Methyl 2,3-dihydro-1H-isoindole-5-carboxylate;2,3-Dihydro-1H-isoindole-5-carboxylic acid methyl ester;1H-Isoindole-5-carboxylic acid, 2,3-dihydro-, methyl ester
• CAS NO: 742666-57-5
• Molecular Formula: C10H11NO2
• Molecular Weight: 177.2
• Mol File: 742666-57-5.mol
• Article Data: 6

Chemical Properties

• Boiling Point: 303.311 °C at 760 mmHg
• Flash Point: 137.238 °C
• Appearance: /
• Density: 1.162
• Storage Temp.: under inert gas (nitrogen or Argon) at 2–8 °C
• CAS DataBase Reference: METHYL ISOINDOLINE-5-CARBOXYLATE(CAS DataBase Reference)
• NIST Chemistry Reference: METHYL ISOINDOLINE-5-CARBOXYLATE(742666-57-5)
• EPA Substance Registry System: METHYL ISOINDOLINE-5-CARBOXYLATE(742666-57-5)

Safety Data

• Hazardous Substances Data: 742666-57-5(Hazardous Substances Data)

Usage

General Description

Methyl isoindoline-5-carboxylate is a chemical compound with the molecular formula C11H9NO2. It is a derivative of isoindoline, a heterocyclic compound, and is commonly used as a building block in the synthesis of various pharmaceuticals, agrochemicals, and other organic compounds. It has been found to exhibit anti-inflammatory, analgesic, and anti-cancer properties, making it a target for drug development. Additionally, methyl isoindoline-5-carboxylate is also used as a raw material in the production of dyes, pigments, and other industrial chemicals.

Upstream product

• 368441-44-5 2-(tert-butyl) 5-methyl isoindoline-2,5-dicarboxylate 
• 201940-08-1 5-bromo-1,3-dihydro-isoindole-2-carboxylic acid tert-butyl ester 
• 67-56-1 methanol 
• 149353-72-0 5-isoindoline carboxylic acid hydrochloride 

Downstream Products

• 914298-91-2 C₂₂H₂₅ClN₂O₆ 
• 914298-90-1 C₂₀H₂₀ClNO₇ 

Relevant articles and documents

SUBSTITUTED PYRROLIDINE AMIDES, THE PRODUCTION THEREOF, AND THE USE THEREOF AS MEDICATIONS

The object of the present invention is novel substituted pyrrolidine amides of the general formula (I) in which D, L. E, G, J, M, L1, L2, R4, and R5 are defined as in the specification, the tautomers, enantiomers, diastereomers, mixtures, and salts thereof, particularly physiologically tolerated salts with inorganic or organic acids or bases having valuable properties.

CARBOXYLIC ACID AMIDES AS FACTOR XA INHIBITORS

The present invention relates to new substituted carboxylic acid amides of general formula (I), wherein D, B, R3, R4 and R5 are defined as in the specification, the tautomers, the enantiomers, the diastereomers, the mixtures thereof and the salts thereof, particularly the physiologically acceptable salts thereof with inorganic or organic acids or bases, which have valuable properties.

MACROCYCLIC CARBOXYLIC ACIDS AND ACYLSULFONAMIDES AS INHIBITORS OF HCV REPLICATION

The present invention provides compounds of the general formulas I-IX, as well as compositions, including pharmaceutical compositions, comprising a subject compound. The present invention further provides treatment methods, including methods of treating a hepatitis C virus infection and methods of treating liver fibrosis, the methods generally involving administering to an individual in need thereof an effective amount of a subject compound or composition.